Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Philom Bios was a pioneering Canadian agricultural biotechnology company focused on the development and commercialization of microbial inoculants to improve crop productivity. Established in 1980 and based in Saskatoon, the company specialized in biological solutions that enhance nutrient uptake, particularly phosphate and nitrogen, in crops like wheat, pulses, and canola. Their portfolio included well-known products such as JumpStart, which utilizes the fungus Penicillium bilaiae to solubilize soil phosphate. In 2007, the company was acquired by the Danish enzyme leader Novozymes for approximately $147 million CAD, serving as a cornerstone for Novozymes' expansion into the global bio-agriculture sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Philom Bios.